New Diabetes Medicine: Protecting the Heart or Hyperbole?
Recorded On: 10/22/2020
After participating in this educational activity, learners will be able to:
• Discuss treatment options for managing adult type 2 diabetes;
• Identify the relevance of these agents in improving renal and cardiovascular outcomes and understand latest treatment guidelines;
• Apply our knowledge to improve glycemic and nonglycemic outcomes.
Craig W. Spellman, DO, FACOI
Professor of Medicine, Division of Endocrinology
Craig W. Spellman, DO, PhD, FACOI, FACE is Professor of Medicine, Division of Endocrinology, at Texas Tech University Health Sciences Center and Director of the MCH Diabetes Center at Medical Center Hospital, Odessa, Texas 2007-present. He was Chair of Endocrinology at the University North Texas Health Science Center from 1997-2007 and served as the Regional Associate Dean for Research at Texas Tech University Health Sciences Center from 2007-2014.
He is Chairman of the subcommittees of the Texas Diabetes Council and Principal and member of the American Osteopathic Association, American College of Osteopathic Internists, American Diabetes Association and the American Association of Clinical Endocrinologists. In addition, Dr. Spellman is an ordained pastor working with 2500 youths in the TeenFLOW ministry, Midland, TX.